Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported STRO revenue for 2026-06-30 was $24.4M. Net income was -$77.0M. Revenue was up 67.7% from 2026-03-31 to 2026-06-30. STRO currently screens at market cap $470.8M.
Use this STRO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the STRO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the STRO SEC filings page. Lician reads the product cache first so this HTML stays unique to Sutro Biopharma even when a live quote feed is slow.
Latest cached year on this hub. Full STRO income, balance, and cash tables.